acetylleucyl-leucyl-norleucinal has been researched along with quercetin in 2 studies
Studies (acetylleucyl-leucyl-norleucinal) | Trials (acetylleucyl-leucyl-norleucinal) | Recent Studies (post-2010) (acetylleucyl-leucyl-norleucinal) | Studies (quercetin) | Trials (quercetin) | Recent Studies (post-2010) (quercetin) |
---|---|---|---|---|---|
321 | 0 | 53 | 12,403 | 239 | 7,510 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Chen, J; Gao, K; Huang, F; Tepe, JJ; Wang, R; Wei, GW | 1 |
Adeli, K; Chen, B; Franke, AA; Theriault, A; Van Iderstine, SC; Wang, Q | 1 |
2 other study(ies) available for acetylleucyl-leucyl-norleucinal and quercetin
Article | Year |
---|---|
Perspectives on SARS-CoV-2 Main Protease Inhibitors.
Topics: Antiviral Agents; Coronavirus 3C Proteases; Humans; Protease Inhibitors | 2021 |
Modulation of hepatic lipoprotein synthesis and secretion by taxifolin, a plant flavonoid.
Topics: Anticholesteremic Agents; Apolipoprotein A-I; Apolipoproteins B; Cholesterol; Dithiothreitol; Flavonols; Humans; Hydrolysis; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Leupeptins; Liver; Quercetin; RNA, Messenger; Tumor Cells, Cultured | 2000 |